United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2005_register
executive
2010-09-23
article
Schedules of Controlled Substances: Placement of Pregabalin into Schedule V
Proposed Rules
D09002ee1bde3c669
D09002ee1bde3c6ee
United States
Department of Justice
originator
org
United States Government Agency or Subagency
United States
Drug Enforcement Administration
originator
org
United States Government Agency or Subagency
This proposed rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid], including its salts, and all products containing pregabalin into Schedule V of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from the Acting Assistant Secretary for Health of the Department of Health and Human Services (DHHS) and on an evaluation of the relevant data by DEA. If finalized, this action will impose the regulatory controls and criminal sanctions applicable to Schedule V non-narcotics on those who handle pregabalin and products containing pregabalin.
70 FR 25502
https://www.govinfo.gov/app/details/FR-2005-05-13/05-9634
05-9634
fr13my05-15
4410-09-P
Docket No. DEA-267P
https://www.govinfo.gov/app/details/FR-2005-05-13/05-9634
https://www.govinfo.gov/content/pkg/FR-2005-05-13/html/05-9634.htm
https://www.govinfo.gov/content/pkg/FR-2005-05-13/pdf/05-9634.pdf
Administrative Practice and Procedure
Drug Traffic Control
Narcotics
Prescription Drugs
4 p.
25502
25505
70 FR 25502
Code of Federal Regulations
Title 21 Part 1308
21 CFR Part 1308
Schedules of Controlled Substances: Placement of Pregabalin into Schedule V; Federal Register Vol. 70, Issue
PRORULE
05-9634
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
2005-06-13
Docket No. DEA-267P
4410-09-P
05-9634
Notice of proposed rulemaking.
This proposed rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid], including its salts, and all products containing pregabalin into Schedule V of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from the Acting Assistant Secretary for Health of the Department of Health and Human Services (DHHS) and on an evaluation of the relevant data by DEA. If finalized, this action will impose the regulatory controls and criminal sanctions applicable to Schedule V non-narcotics on those who handle pregabalin and products containing pregabalin.
Written comments must be postmarked, and electronic comments must be sent, on or before June 13, 2005.
Christine Sannerud, Ph.D., Chief, Drug and Chemical Evaluation Section, Drug Enforcement Administration, Washington, DC 20537, (202) 307-7183.
Administrative Practice and Procedure
Drug Traffic Control
Narcotics
Prescription Drugs
Schedules of controlled substances:
Pregabalin; placement into Schedule V,
dea.diversion.policy@usdoj.gov
http://www.regulations.gov
Federal Register
Vol. 70, no. 92
Office of the Federal Register, National Archives and Records Administration
2005-05-13
continuing
daily
deposited
born digital
305 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2005-05-13
P0b002ee18098f411
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr13my05
https://www.govinfo.gov/app/details/FR-2005-05-13
https://www.govinfo.gov/content/pkg/FR-2005-05-13/pdf/FR-2005-05-13.pdf
https://www.govinfo.gov/content/pkg/FR-2005-05-13/xml/FR-2005-05-13.xml
fdlp
25457
25752
DGPO
2010-09-23
2023-05-03
FR-2005-05-13
machine generated
eng
FR
FR-2005-05-13
70
92